From The Newsrooms

Jonathan E. Alpert, MD, PhD, discusses which medical conditions are associated with high rates of depression and evidence gaps in the research on people with depression and medical comorbidities.

Acknowledging that addiction is a crisis that “touches families in every community in red states and blue states, across all races and creeds,” President Joe Biden told Rx Drug Abuse & Heroin Summit attendees in prepared remarks presented on Monday that his administration will face the challenge head-on.

In his opening remarks at the Rx Drug Abuse & Heroin Summit on Monday, U.S. Rep. Hal Rogers said a multi-pronged approach – law enforcement, treatment and education – remains the best path forward in tackling the opioid crisis.

Dan Schneider, the subject of a Netflix series that chronicled efforts to track down the individual who killed his son in a drug deal gone bad, has formed a lobbying group to advocate for education, recovery, treatment and research to address the nation’s opioid crisis.

Veterans Health Administration officials discuss opioid risk mitigation strategies, keys for aligning stakeholders in their mission, and changes made in light of the COVID-19 pandemic.

Adolescents and young adults who were born preterm have higher rates of psychotropic drug prescriptions than their peers who were born at full term, according to a study published online in JAMA Network Open.

Epidemiologists from the West Virginia Board of Pharmacy discuss how non-fatal overdose data was integrated into the state’s prescription drug monitoring database and how that move has helped prescribers across the state.

ADHD Section Editor and Psych Congress Steering Committee member Vladimir Maletic, MD, MS, discusses recent research developments regarding late-onset ADHD and questions that remain unanswered.

More than a quarter of US adults with schizophrenia received a diagnosis of dementia before 66 years of age, according to a study published online ahead of print in JAMA Psychiatry. 

The high co-occurrence rates of bipolar disorder (BD) and attention/deficit-hyperactivity disorder (ADHD) indicate clinicians need to routinely carry out screenings for adults with either condition, according to a meta-analysis published online.